Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer

This study has been completed.
Information provided by (Responsible Party):
National Cancer Institute (NCI) Identifier:
First received: July 26, 2006
Last updated: September 16, 2016
Last verified: September 2016
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: October 2015
  Primary Completion Date: October 2015 (Final data collection date for primary outcome measure)